SCHEMBL29796614

SCHEMBL29796614

COc1[nH]nc(-c2cccc(C)n2)c1-c1ccc2ncc(-c3cccnc3)cc2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRB P09619 2/20 0.45
▸ PDGFRA P16234 2/20 0.45
▸ CYP2A6 P11509 2/20 0.44
▸ TGFBR1 P36897 6/20 0.41
▸ FGFR1 P11362 2/20 0.40
▸ KDR P35968 2/20 0.40
▸ FGFR2 P21802 1/20 0.40
▸ FGFR4 P22455 1/20 0.40
▸ FGFR3 P22607 1/20 0.40
▸ CLK2 P49760 4/20 0.39
▸ DYRK1A Q13627 4/20 0.39
▸ CLK3 P49761 3/20 0.39
▸ PIM1 P11309 5/20 0.38
▸ GRM5 P41594 1/20 0.38
▸ MAPK14 Q16539 1/20 0.37
▸ CHEK1 O14757 1/20 0.36
▸ AURKA O14965 1/20 0.36
▸ DAPK3 O43293 1/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ PRKD3 O94806 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23389913 1.00 PDGFRB (0.45) PDGFRBPDGFRACYP2A6TGFBR1FGFR1
SCHEMBL25084603 0.84 PDGFRB (0.47) PDGFRBPDGFRACYP2A6TGFBR1FGFR1
SCHEMBL30156319 0.84 PDGFRB (0.47) PDGFRBPDGFRACYP2A6TGFBR1FGFR1
SCHEMBL29796620 0.82 TGFBR1 (0.40) TGFBR1MAPK14
SCHEMBL23407940 0.82 TGFBR1 (0.38) TGFBR1MAPK14
SCHEMBL29796618 0.82 TGFBR1 (0.38) TGFBR1GRM5MAPK14
SCHEMBL23389969 0.82 TGFBR1 (0.38) TGFBR1GRM5MAPK14
SCHEMBL23390032 0.82 TGFBR1 (0.40) TGFBR1MAPK14
SCHEMBL25084880 0.82 CYP2A6 (0.46) PDGFRBPDGFRACYP2A6TGFBR1FGFR1
SCHEMBL30156631 0.82 CYP2A6 (0.46) PDGFRBPDGFRACYP2A6TGFBR1FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4061809-A1 SUBSTITUTED 1,5-NAPHTHYRIDINES OR QUINOLINES AS ALK5 INHIBITORS Theravance Biopharma R&D IP, LLC (US) 2022-09-28 — — EP disclosed
CN-114728941-A Substituted 1, 5-naphthyridines or quinolines as ALK5 inhibitors 施万生物制药研发IP有限责任公司 2022-07-08 — — CN disclosed
Send feedback